Quaker Houghton Stock Falls 1.88% Below $187 Target
Quaker Houghton shares dropped 1.88% to $160.38, trading below the $187 analyst target despite reporting strong quarterly revenue of $532.55 million and an earnings per share beat.
Quaker Houghton shares dropped 1.88% to $160.38, trading below the $187 analyst target despite reporting strong quarterly revenue of $532.55 million and an earnings per share beat.
Yahoo Finance provides an overview of Quaker Chemical Corporation (KWR), detailing its stock price, financial metrics, and specialty chemicals business. The page highlights recent dividend announcemen
Quaker Chemical's stock performance aligns with strong earnings, with analysts projecting higher future profits due to non-recurring cost adjustments. The company has returned to profitability this ye
RBC Capital maintained a Buy rating on Quaker Chemical with a $198 price target following strong Q2 earnings. The company reported $532.55 million in revenue and turned a net loss into a $26.84 millio
Analysts raised Quaker Chemical's average price target to $177, implying a 14% upside from recent closing prices. The consensus rating remains "Buy" among all covering analysts.
Quaker Chemical Corporation increased its quarterly dividend to $0.53 per share, up from $0.508. The payment is scheduled for October 30 to shareholders of record as of October 16.
Quaker Houghton increased its quarterly cash dividend by 4.3% to $0.53 per share, marking 17 consecutive years of growth. The move reflects strong cash flow generation and strategic capital allocation
Quaker Chemical Corp highlighted its specialty fluids business amid investor interest in industrial demand. The global supplier of process chemicals for metalworking and manufacturing emphasizes techn
Quaker Chemical Corporation's Quaker PrimeCut 250 is a semi-synthetic metalworking fluid utilized in US machining operations to enhance tool life and stability. The product supports Quaker Houghton's
Quaker Chemical Corporation expanded its China operations with a new Zhangjiagang manufacturing facility and an enlarged Shanghai laboratory. These moves aim to strengthen its Asia-Pacific footprint f
Quaker Chemical expanded its China operations with a new Zhangjiagang facility and enhanced Shanghai laboratory to strengthen its Asia-Pacific presence. It targets $2.2 billion in revenue by 2029 amid
Quaker Houghton opened a new manufacturing facility in Zhangjiagang, China, and expanded its Shanghai lab to meet growing Asia-Pacific demand. The expansion supports production of die casting and grea
Quaker-Houghton, a global leader in industrial process fluids and specialty lubricants, is relocating its headquarters and laboratory from Conshohocken to Radnor, Pennsylvania. The phased move begins
This article analyzes Quaker Chemical Corporation's stock, focusing on its long-term strategy and earnings outlook. It highlights the company's role as a supplier of process fluids for heavy industry
UBS Group AG reduced its stake in Quaker Houghton by 21.5% in Q4 2025. Quaker Chemical reported 8.5% revenue growth and announced a $250 million share repurchase program.
Quaker Houghton announced a $0.508 quarterly dividend payable on July 31, 2026, alongside a new $250 million stock repurchase program. The initiative aims to balance growth priorities with disciplined
Quaker Houghton declared a quarterly dividend and authorized a $250 million stock repurchase program. The announcement was reported by Refinitiv and attributed to Thomson Reuters.
Quaker Houghton announced a quarterly cash dividend of $0.508 per share and authorized a new $250 million stock repurchase program to enhance shareholder returns.
Quaker Chemical announced a three-year cost reduction program targeting $20 million to $30 million in annual savings. The initiative aims to optimize operational efficiency amid anticipated Q2 gross m
Quaker Houghton reported Q1 2026 net sales of $480.5 million, up 8%, while extending debt maturity to 2031 and launching a cost-saving program targeting $20-30 million annually by 2028.
Freedom Capital analyst David Silver initiated coverage of Quaker Chemical Corporation with a Buy rating and $180 price target, citing potential gains from global industrial recovery and re-shoring tr
Freedom Broker initiated coverage on Quaker Houghton with a buy rating and $180 price target, citing recession-resistant business and industrial recovery potential following Q4 2025 earnings.
Quaker Chemical amended its credit agreement to extend debt maturities to 2031 and expand facilities to $800 million, aiming to enhance financial flexibility for growth. However, investors remain caut
Quaker Chemical shares rebounded recently, sparking a valuation debate with conflicting fair value estimates between $103.25 and $183. Investors are advised to weigh cost optimization narratives again
Quaker Houghton announced it will release its first quarter 2026 financial results after market close on April 30, 2026. An investor teleconference will follow on May 1 at 8:00 a.m. ET.
Zacks Research downgraded Quaker Houghton to a "Strong Sell" rating following an earnings miss, though revenue exceeded expectations. Analyst consensus remains "Hold" with a price target of $179.50.
Quaker Houghton shares dropped 3.6% to $137.31, while GuruFocus identifies the stock as 18.4% undervalued with a GF Score of 80 despite low predictability.
Quaker Houghton amended its credit agreement to extend debt maturity to 2031, securing a $550 million term loan and $800 million revolving facility. This strengthens liquidity to support future invest
Seaport Global Securities upgraded Quaker Chemical to Buy with a $175 price target, citing pricing power against elevated input costs. Analysts also highlighted positive sentiment for peer Quaker Houg
Quaker Houghton has announced the schedule for its Q1 2026 earnings release on April 30, 2026, and an investor call on May 1, 2026.
Quaker Chemical Corporation announced its Q1 2026 earnings release date and investor teleconference schedule. The company will publish results after market close on April 30, 2026.
Quaker Chemical's stock shows mixed performance with conflicting valuation analyses suggesting either undervaluation at $183 or overvaluation near $102. Investors are advised to weigh strategic invest
Quaker Houghton extended debt maturity to 2031 and secured an $800 million revolving facility to improve liquidity, despite reporting a net loss in 2025. While financial flexibility supports growth, i
Quaker Houghton amended its credit agreement to extend debt maturities to 2031 and increased its revolving credit facility to $800 million. CEO Joseph Berquist stated the deal strengthens the balance
Quaker Houghton declared a quarterly dividend of $0.508 per share, payable April 30th, continuing a 17-year streak of annual increases. Analysts expect the payout ratio to remain well-covered at aroun
Deprince Race & Zollo increased its stake in Quaker Houghton by 9.7% in Q4, holding shares worth $38.25 million. The company declared a quarterly dividend of $0.508 per share while analysts maintain a
RBC Capital cut Quaker Chemical's price target to $184 due to weak Q4 results, contrasting with Deutsche Bank's raise to $170, as analysts weigh returns against AI sectors.
Wall Street Zen downgraded Quaker Houghton to a "Hold" rating with a $179.50 target price following Q4 earnings that missed EPS estimates. Other analysts like Jefferies and RBC have also reduced their
Jefferies lowered its price target for specialty chemicals firm Quaker Houghton to $175 while maintaining a buy rating. The company reported Q4 revenue of $468.5 million beating expectations despite m
Allspring Global Investments reduced its stake in Quaker Houghton by 7.1% in Q4. The specialty chemicals firm reported an EPS miss but beat revenue estimates and declared a quarterly dividend.
Quaker Chemical Corporation announced its 2026 Annual Meeting will be virtual on May 13, covering director elections and executive pay. The company reported 2025 net sales of $1.89 billion and recomme
Penn Capital Management reduced its stake in Quaker Houghton by selling 12,903 shares in Q3. The chemical firm reported $1.65 EPS and a $0.508 dividend despite a minor stock drop.